FDA Commissioner Warns Against Lowering Safety, Effectiveness Standards

Outgoing FDA Commissioner Margaret Hamburg cautioned members of the Senate health committee Tuesday (March 10) not to lower safety and effectiveness standards as they push to speed up patient access to medical products, and also urged them to look beyond National Institutes of Health funding needs and also adequately fund FDA, saying that this is “one of the disconnects that worries me a lot.” Her comments were echoed by leading Democrats on the committee, and come as key consumer advocates...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.